{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":3,"sponsored":0,"items":[{"id":"n_cucfmimfot7zscvq3rla","seq":1210219,"kind":"press_release","title":"NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier","url":"https://www.globenewswire.com/news-release/2026/10/01/3373402/0/fr/nanobiotix-annonce-la-nomination-d-arnd-christ-au-poste-de-directeur-financier.html","summary":"PARIS et CAMBRIDGE, Mass., 01 oct. 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur la physique pour élargir les possibilités de traitement des patients atteints de cancer ou d’autres maladies, a annoncé aujourd'hui la nomination d’Arnd Christ au poste de directeur financier ( Chief Financial Officer ) et de membre du…","published":"2026-10-01T20:15:00Z","seen":"2026-10-01T20:20:08Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business","paris:nano","nasdaq: nbtx","fr0011341205","us63009j1079"],"entities":[{"id":"Q6963996","name":"Nanobiotix","type":"org"}],"story":"st_cucfmimfot7zscvq3rla","category":"economy-business","category_p":0.91,"sentiment":"neutral","tone":0.13,"political":0.04},{"id":"n_l2nmx6dknlputi7w4y5q","seq":1210218,"kind":"press_release","title":"NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer","url":"https://www.globenewswire.com/news-release/2026/10/01/3373402/0/en/nanobiotix-announces-the-appointment-of-arnd-christ-as-chief-financial-officer.html","summary":"PARIS and CAMBRIDGE, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced the appointment of Arnd Christ as chief financial officer and member of the Company’s executive board, effective October 1, 2026. Mr. Christ brings more than two decades of…","published":"2026-10-01T20:15:00Z","seen":"2026-10-01T20:20:08Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business","paris:nano","nasdaq: nbtx","fr0011341205","us63009j1079"],"entities":[{"id":"Q6963996","name":"Nanobiotix","type":"org"}],"story":"st_cucfmimfot7zscvq3rla","category":"economy-business","category_p":0.9,"sentiment":"neutral","tone":0.15,"political":0.04},{"id":"n_ajcyqe4uvpv2saplekhq","seq":514874,"kind":"article","title":"Can J&J's Partnership Drive More Upside for Nanobiotix?","url":"https://www.insidermonkey.com/news/can-jjs-partnership-drive-more-upside-for-nanobiotix-1845930","published":"2026-09-28T20:08:19Z","seen":"2026-09-28T20:08:19Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"authors":["Noor Ul Ain Rehman"],"entities":[{"id":"Q333718","name":"Johnson & Johnson","type":"org"},{"id":"Q6963996","name":"Nanobiotix","type":"org"}],"story":"st_ajcyqe4uvpv2saplekhq","category":"economy-business","category_p":0.64,"sentiment":"positive","tone":0.37,"political":0.03}]}